Cargando…

Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship

AIM: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the general population. Overweight is a common condition in patients with NAFLD, and body composition (BC) assessment is useful to evaluate nutritional status and the efficacy of nutritional strategies. A vali...

Descripción completa

Detalles Bibliográficos
Autores principales:	ABENAVOLI, LUDOVICO, DI RENZO, LAURA, GUZZI, PIETRO HIRAM, PELLICANO, RINALDO, MILIC, NATASA, DE LORENZO, ANTONINO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iuliu Hatieganu University of Medicine and Pharmacy 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689242/ https://www.ncbi.nlm.nih.gov/pubmed/26733747 http://dx.doi.org/10.15386/cjmed-595

Ejemplares similares

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease
por: Gelli, Chiara, et al.
Publicado: (2017)

Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study
por: Abenavoli, Ludovico, et al.
Publicado: (2017)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Comment on Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
por: Abenavoli, Ludovico, et al.
Publicado: (2020)

When the microbiome helps the brain‐current evidence
por: Drljača, Jovana, et al.
Publicado: (2023)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention
por: Di Renzo, Laura, et al.
Publicado: (2014)

Influence of FTO rs9939609 and Mediterranean diet on body composition and weight loss: a randomized clinical trial
por: Di Renzo, Laura, et al.
Publicado: (2018)

Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes
por: Tsamos, Georgios, et al.
Publicado: (2023)

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
por: Dallio, Marcello, et al.
Publicado: (2019)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)

Comment on “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2017)

Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals
por: Dai, Huajie, et al.
Publicado: (2021)

Fat mass affects nutritional status of ICU COVID-19 patients
por: De Lorenzo, Antonino, et al.
Publicado: (2020)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Visualization of protein interaction networks: problems and solutions
por: Agapito, Giuseppe, et al.
Publicado: (2013)

Using miRNA-Analyzer for the Analysis of miRNA Data
por: Guzzi, Pietro Hiram, et al.
Publicado: (2016)

A Parallel Software Pipeline for DMET Microarray Genotyping Data Analysis
por: Agapito, Giuseppe, et al.
Publicado: (2018)

Spatio-Temporal Resource Mapping for Intensive Care Units at Regional Level for COVID-19 Emergency in Italy
por: Guzzi, Pietro Hiram, et al.
Publicado: (2020)

Using dual-network-analyser for communities detecting in dual networks
por: Guzzi, Pietro Hiram, et al.
Publicado: (2022)

Beyond COVID-19 pandemic: Topology-aware optimization of vaccination strategy for minimizing virus spreading
por: Petrizzelli, Francesco, et al.
Publicado: (2022)

Design and Implementation of a New Local Alignment Algorithm for Multilayer Networks
por: Milano, Marianna, et al.
Publicado: (2022)

Editorial: Graph representation learning in biological network
por: Roy, Swarup, et al.
Publicado: (2023)

Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
por: Zhang, Shengkui, et al.
Publicado: (2022)

Editorial: Global excellence in gastroenterology: Europe
por: Abenavoli, Ludovico
Publicado: (2023)

Aligning Cross-Species Interactomes for Studying Complex and Chronic Diseases
por: Milano, Marianna, et al.
Publicado: (2023)

Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis
por: Das, Jayanta Kumar, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle
por: Poggiogalle, Eleonora, et al.
Publicado: (2017)

L-HetNetAligner: A novel algorithm for Local Alignment of Heterogeneous Biological Networks
por: Milano, Marianna, et al.
Publicado: (2020)

Structural analysis of SARS-CoV-2 Spike protein variants through graph embedding
por: Guzzi, Pietro Hiram, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?
por: Longato, Lisa
Publicado: (2013)

The Legacy of Renato Dulbecco in the Post-Genomic Era
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Recent Advances and Future Challenges in the Field of Digestive Diseases
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

COVID-19: Where We Are and Where We Are Going
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dnvd9rgpr3a3d9hkitr8rh7bae